Limited Value of the Multi‐Biomarker Disease Activity Assay Compared to the Routine Assessment of Patient Index Data 3 (RAPID3) Score in the Prognosis of Important Clinical Outcomes in Rheumatoid Arthritis: Comment on the Article by Fleischmann et al and Accompanying Editorial by Davis. Issue 4 (3rd March 2017) - Pincus, Theodore; Block, Joel A.; Yazici, Yusuf; Bergman, Martin J.; Sokka, Tuulikki